Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-01-14

FDA Approved: LEVETIRACETAM — Supplemental Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approved a supplemental application for levetiracetam from Torrent Pharmaceuticals Limited, enabling the marketing of a generic version.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • LEVETIRACETAM (levetiracetam)

Snippet

SUPPL AP for LEVETIRACETAM (LEVETIRACETAM)